- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aardvark Therapeutics Inc (AARD)
Aardvark Therapeutics Inc stock price live, this page displays NASDAQ AARD stock exchange data. View the AARD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aardvark Therapeutics Inc real time stock price chart below.
What Is the Aardvark Therapeutics Inc Stock Price Today?
The Aardvark Therapeutics Inc stock price today is 1.330.
What Is the Stock Symbol for Aardvark Therapeutics Inc?
The stock symbol for Aardvark Therapeutics Inc is "AARD."
What Stock Exchange Does Aardvark Therapeutics Inc Trade On?
Aardvark Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Aardvark Therapeutics Inc a Good Stock to Buy?
Determining whether Aardvark Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AARD quote. (ISIN: US0029421007)
What Is the Aardvark Therapeutics Inc Stock Price Today?
The Aardvark Therapeutics Inc stock price today is 1.330.
What Is the Stock Symbol for Aardvark Therapeutics Inc?
The stock symbol for Aardvark Therapeutics Inc is "AARD."
What Stock Exchange Does Aardvark Therapeutics Inc Trade On?
Aardvark Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Aardvark Therapeutics Inc a Good Stock to Buy?
Determining whether Aardvark Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AARD quote. (ISIN: US0029421007)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.310
1.700
52 wk Range
0.930
16.600
AARD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.3101.700
52 wk Range
0.93016.600
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AARD Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
4.571
Upside
+243.72%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- Form 8K Aardvark Therapeutics Inc For: 13 November
- Investing.com
- Form 8K Aardvark Therapeutics Inc For: 13 November
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
4 Buy
5 Hold
2 Sell
Ratings:
11 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 4.571
(+243.72% Upside)
Earnings
Latest Release
Nov 13, 2026
EPS / Forecast
-0.88 / -0.80
Revenue / Forecast
-- / --
Compare AARD to Peers and Sector
Metrics to compare | AARD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAARDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −1.2x | −0.2x | |
PEG Ratio | −0.07 | −0.05 | 0.00 | |
Price/Book | 0.5x | 1.0x | 2.6x | |
Price / LTM Sales | - | 13.5x | 2.8x | |
Upside (Analyst Target) | 243.7% | 363.5% | 61.2% | |
Fair Value Upside | Unlock | 5.5% | 9.7% | Unlock |
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Aardvark Therapeutics (AARD) Stock Price Today?
The Aardvark Therapeutics stock price today is 1.330 USD.
What Stock Exchange Does Aardvark Therapeutics Trade On?
Aardvark Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Aardvark Therapeutics?
The stock symbol for Aardvark Therapeutics is "AARD."
What Is the Aardvark Therapeutics Market Cap?
As of today, Aardvark Therapeutics market cap is 29.110M USD.
What Is Aardvark Therapeutics's Earnings Per Share (TTM)?
The Aardvark Therapeutics EPS (TTM) is -3.33.
From a Technical Analysis Perspective, Is AARD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Aardvark Therapeutics Stock Split?
Aardvark Therapeutics has split 0 times.
How Many Employees Does Aardvark Therapeutics Have?
Aardvark Therapeutics has 28 employees.
What is the current trading status of Aardvark Therapeutics (AARD)?
As of Nov 15, 2026, Aardvark Therapeutics (AARD) is trading at a price of 1.330 USD, with a previous close of 1.330 USD. The stock has fluctuated within a day range of 1.310 USD to 1.700 USD, while its 52-week range spans from 0.930 USD to 16.600 USD.
What Is Aardvark Therapeutics (AARD) Price Target According to Analysts?
The average 12-month price target for Aardvark Therapeutics is 4.571 USD, with a high estimate of 10 USD and a low estimate of 1.5 USD. 4 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +243.72% Upside potential.
What Is the AARD Premarket Price?
AARD's last pre-market stock price is 1.487 USD. The pre-market share volume is 1,000.000, and the stock has decreased by -0.033, or -2.170%.
What Is the AARD After Hours Price?
AARD's last after hours stock price is 1.352 USD, the stock has decreased by 0.022, or 1.640%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.